Astrana Health, Inc. Proceeds from Sale of Equity Method Investments
Astrana Health, Inc. (ASTH) reported Proceeds from Sale of Equity Method Investments of $15.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2026-03-12
- Astrana Health, Inc. proceeds from sale of equity method investments for the quarter ending 2025-12-31 was $0.00.
- Astrana Health, Inc. proceeds from sale of equity method investments for the quarter ending 2024-12-31 was $0.00.
- Astrana Health, Inc. proceeds from sale of equity method investments for the quarter ending 2022-12-31 was $0.00.
- Astrana Health, Inc. proceeds from sale of equity method investments for the quarter ending 2021-12-31 was $0.00.
- Astrana Health, Inc. proceeds from sale of equity method investments for fiscal 2025 was $15.10M.
- Astrana Health, Inc. proceeds from sale of equity method investments for fiscal 2024 was $0.00.
- Astrana Health, Inc. proceeds from sale of equity method investments for fiscal 2023 was $0.00.
- Astrana Health, Inc. proceeds from sale of equity method investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $15.10M 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $15.10M 10-Q · filed 2025-11-10 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.38M derived: sum of 2 quarters · filed 2024-02-29 | $6.38M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $6.38M 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | |||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-09 | $0.00 derived: sum of 2 quarters · filed 2023-08-09 | $52.74M 10-K/A · filed 2023-08-09 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $52.74M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $52.74M 10-Q · filed 2021-08-06 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |
| Information Services Group Inc. (III) | United States | $0.256B | 16.97 |
| HACKETT GROUP, INC. (HCKT) | United States | $0.254B |